Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-21

Clinical Trial Update: Buprenorphine Dose Adjustments and Gestational Age

View source ↗

Summary

A completed clinical trial from St. Louis University evaluating how buprenorphine dosing can be adjusted by gestational age in neonatal abstinence syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: St. Louis University | Conditions: Neonatal Abstinence Syndrome | Status: COMPLETED